FDA-Drug2025-11-05Class III
Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91
Endo USA, Inc.
Hazard
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Sold states
Nationwide within the United States
Affected count
2,035 cartons
Manufactured in
9 Great Valley Pkwy, N/A, Malvern, PA, United States
Products
Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0142-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief